Ribonucleotide reductase regulatory subunit M2 (RRM2) is implied in a variety of cancers, consisting of glioma, bladder cancer, and lung cancer [21], and correlated with ferroptosis in a GSH-dependent manner [22]. Here, RRM2 is linked to lung carcinoma.